Top brokers name 3 ASX shares to sell next week

Brokers aren't feeling very positive about these shares…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Once again, a large number of broker notes hit the wires last week. Some of these notes were positive and some were bearish.

Three sell ratings that caught my eye are summarised below. Here's why top brokers think investors ought to sell these shares next week:

Fortescue Metals Group Limited (ASX: FMG)

According to a note out of Morgans, its analysts have retained their reduce rating and cut their price target on this iron ore producer's shares to $19.20. While Fortescue delivered a full year result in line with the broker's expectations, it has questions over the company's target of becoming a global technology leader in renewables and green products. As worthy as this is, Morgans wonders whether being an early adopter would be a more efficient approach rather than an innovator. Especially given how it is moving into a space far outside its established core competencies. The Fortescue share price ended the week at $20.85.

InvoCare Limited (ASX: IVC)

A note out of Macquarie reveals that its analysts have retained their underperform rating but increased their price target on this funerals company's shares to $9.90. This follows the release of a solid half year result, which outperformed its expectations. However, Macquarie appears to believe a lot of this strong first half will be underdone in the second half due to lockdown headwinds. In light of this, the broker doesn't see enough value in its shares to change its rating. The InvoCare share price was fetching $12.52 at Friday's close.

Wesfarmers Ltd (ASX: WES)

Analysts at Citi have retained their sell rating and lifted their price target on this conglomerate's shares to $49.00. According to the note, the broker was pleased with Wesfarmers' performance in FY 2021 and its $2.3 billion capital return announcement. And while this has led to an increase in both its earnings estimates and price target. It isn't enough for a more positive rating. Citi continues to believe that Wesfarmers' shares are overvalued at the current level. The Wesfarmers share price ended the week at $57.78.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Wesfarmers Limited. The Motley Fool Australia has recommended InvoCare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A woman holds her finger to the side of her face and looks upwards as she thinks about something.
Broker Notes

4 ASX shares at 52-week lows: Buy, hold, or sell?

Here's what the experts think.

Read more »

A female athlete in green spandex leaps from one cliff edge to another representing 3 ASX shares that are destined to rise and be great
Broker Notes

Up 57% since February, why Telix shares could keep leaping higher in 2026

A leading analyst believes investors are undervaluing Telix shares. But why?

Read more »

A happy young woman in a red t-shirt hold up two delicious burritos.
Broker Notes

Guzman Y Gomez shares just sank to new all-time lows. Time to buy?

A leading analyst provides his outlook for the battered Guzman Y Gomez share price.

Read more »